Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

17.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Phage Display to Create Recombinant Antibodies.

Cold Spring Harbor protocols·2017
Same author

Modification of Antibody Function by Mutagenesis.

Cold Spring Harbor protocols·2017
Same author

Creation of Recombinant Antibodies: Using Degenerate Oligonucleotides to Amplify Heavy- and Light-Chain Sequences.

Cold Spring Harbor protocols·2017
Same author

Creation of Recombinant Antibodies: Using 5'-RACE to Amplify Immunoglobulin Sequences.

Cold Spring Harbor protocols·2017

Related Experiment Video

Updated: Feb 21, 2026

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

11.0K

Rescue Strategy for Nonviable Hybridomas: Amplifying Heavy- and Light-Chain Sequences from Genomic DNA by Polymerase

James R Dasch, Amy L Dasch

    Cold Spring Harbor Protocols
    |October 5, 2017
    PubMed
    Summary

    Researchers can recover lost hybridoma antibody sequences using genomic DNA and PCR. This method rescues heavy- and light-chain variable genes from nonviable hybridomas when mRNA is degraded.

    More Related Videos

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology
    09:42

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology

    Published on: January 2, 2017

    43.8K
    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
    10:32

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

    Published on: June 5, 2015

    19.4K

    Related Experiment Videos

    Last Updated: Feb 21, 2026

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
    13:14

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

    Published on: February 6, 2018

    11.0K
    Generation of Murine Monoclonal Antibodies by Hybridoma Technology
    09:42

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology

    Published on: January 2, 2017

    43.8K
    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
    10:32

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

    Published on: June 5, 2015

    19.4K

    Area of Science:

    • Immunology
    • Molecular Biology
    • Biotechnology

    Background:

    • Hybridomas are crucial for antibody production but can be lost due to instability or freezer failure.
    • Degradation of mRNA in nonviable hybridomas often prevents the retrieval of antibody gene sequences.
    • Existing cloning methods typically rely on intact mRNA, limiting recovery options.

    Purpose of the Study:

    • To develop a method for recovering heavy- and light-chain variable (V) gene sequences from nonviable hybridomas.
    • To provide an alternative approach for rescuing valuable hybridoma cell lines when mRNA is degraded.

    Main Methods:

    • Utilizing genomic DNA from nonviable hybridomas, which is more stable than mRNA.
    • Employing Polymerase Chain Reaction (PCR) with a specific set of primers targeting conserved regions.
    • Primers target the 5' untranslated region of VH and VL genes and the JH and JL segments.

    Main Results:

    • Successful recovery of full-length heavy- and light-chain V gene sequences from degraded hybridoma samples.
    • Demonstration of a viable alternative to mRNA-dependent methods for hybridoma rescue.

    Conclusions:

    • This genomic DNA-based PCR method enables the retrieval of essential antibody gene sequences from lost or compromised hybridomas.
    • The technique offers a valuable strategy for preserving and rescuing valuable hybridoma resources in research settings.